logo

VSEE

VSee Health·NASDAQ
--
--(--)
--
--(--)
0.52 / 10
Underperform

Fundamentally the stock underperforms, scoring 0.5/10. Profitability metrics like Profit‑MV and Net‑income‑Revenue are poor, while interest coverage (15.6x) and long‑term debt to working capital (27%) are modest positives. Overall financial health is guarded.

Fundamental(0.52)SentimentTechnical

Analysis Checks(3/10)

Profit-MV
Value0.41
Score1/3
Weight15.14%
1M Return-3.58%
Net income-Revenue
Value-0.16
Score1/3
Weight18.38%
1M Return-4.57%
Quick ratio
Value2.20
Score1/3
Weight11.26%
1M Return-2.25%
Rate of return on total assets (%)
Value-26.45
Score0/3
Weight24.47%
1M Return-6.21%
Fixed assets turnover ratio
Value15.12
Score1/3
Weight9.99%
1M Return-2.10%
Long-term debt to working capital ratio (%)
Value26.99
Score2/3
Weight11.66%
1M Return-2.49%
Annualized return on total assets (%)
Value-35.26
Score0/3
Weight24.47%
1M Return-6.21%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.64
Score2/3
Weight9.67%
1M Return-1.91%
Asset-MV
Value-0.48
Score3/3
Weight-49.08%
1M Return8.48%
Current assets / Total assets (%)
Value19.88
Score0/3
Weight24.06%
1M Return-4.55%
Is VSEE fundamentally strong?
  • VSEE scores 0.52/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -69.81% net margin, -0.97 P/E ratio, -1.75 P/B ratio, and 106.75% earnings growth, these metrics solidify its Underperform investment rating.